✨ Environmental and Health Notices




2544 NEW ZEALAND GAZETTE, No. 90 30 JUNE 2011

Note: The above notice is published in addition to notices of Final Allocations for Eligible Fishing Quota Owners, which were published in Supplements to the New Zealand Gazette, 24 September 2010, No. 125, page 3313, and New Zealand Gazette, 29 March 2011, No. 37, page 947.

2. Publishing Industrial Allocations

Section 86B(6)(b) of the Climate Change Response Act 2002 requires the Chief Executive of the Ministry for the Environment to publish the allocation of NZUs received by individuals and businesses. When publishing the allocations, the chief executive must consider whether publishing a final allocation of NZUs would "...be likely to prejudice unreasonably the commercial position of the eligible person who received the allocation."

While consulting with stakeholders, a number of issues have been identified concerning the sensitivity of commercial information that is not normally publicly available. To ensure that the continued commercial activity of small family-owned entities is protected, further analysis will be undertaken. At this time, no allocation information will be published until the issues are addressed.

When the Ministry for the Environment is satisfied that all entities can be treated fairly and consistently, further information on the allocation of NZUs will be published in the New Zealand Gazette.

Dated at Wellington this 27th day of June 2011.

KEVIN CURRIE, Director of Environmental Protection.

1 These names are from the fishing quota register as of 24 September 2009, some of which may have changed due to succession issues.

go4408

Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Codral Cold & Flu
Active Ingredients:
Codeine phosphate hemihydrate 9.5mg equivalent to codeine 7.03mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg equivalent to phenylephrine 4.1mg
Dosage Form: Tablet
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: Probiotec Pharma Pty Limited, Laverton North, Australia

Product: Codral Nightime Cold & Flu
Active Ingredients:
Chlorphenamine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturers:
Pfizer Laboratories (Pty) Limited, Cape Town, South Africa
Janssen-Cilag, Val de Reuil, France

Product: Sinutab PE Phenylephrine Sinus & Pain Relief (General Sale)
Active Ingredients:
Paracetamol 500mg
Phenylephrine hydrochloride 5mg equivalent to phenylephrine 4.1mg
Dosage Form: Tablet
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturers:
Pfizer Laboratories (Pty) Limited, Cape Town, South Africa
Janssen-Cilag, Val de Reuil, France

Product: Sinutab PE Phenylephrine Sinus & Pain Relief (Pharmacy Only)
Active Ingredients:
Paracetamol 500mg
Phenylephrine hydrochloride 5mg equivalent to phenylephrine 4.1mg
Dosage Form: Tablet
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: Pfizer Laboratories (Pty) Limited, Cape Town, South Africa



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2011, No 90





✨ LLM interpretation of page content

πŸ›οΈ Publishing Industrial Allocations

πŸ›οΈ Governance & Central Administration
27 June 2011
Climate Change Response Act, NZUs, Industrial Allocations, Commercial Sensitivity
  • KEVIN CURRIE, Director of Environmental Protection

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines Act, New Medicines, Consent, Distribution